SCHEMBL8053708

SCHEMBL8053708

CC(=O)Nc1cc2c(cc1C(=O)CCl)OCO2

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 12/20 0.57
ALDH1A1 P00352 9/20 0.57
HSD17B10 Q99714 5/20 0.57
ALOX15 P16050 1/20 0.57
MEN1 O00255 1/20 0.56
POLB P06746 1/20 0.56
KMT2A Q03164 1/20 0.56
HPGD P15428 4/20 0.52
MAPT P10636 1/20 0.52
NPSR1 Q6W5P4 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
CYP2C19 P33261 2/20 0.50
MAPK1 P28482 1/20 0.50
TSHR P16473 3/20 0.49
CASP1 P29466 1/20 0.49
TDP1 Q9NUW8 2/20 0.48
GAA P10253 1/20 0.48
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30884749 0.85 KDM4E (0.57) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL21450559 0.85 KDM4E (0.57) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL29084613 0.85 KDM4E (0.57) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL8961778 0.83 KDM4E (0.55) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL21450560 0.83 KDM4E (0.81) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL30884801 0.83 KDM4E (0.81) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL26915140 0.80 HPGD (0.52) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL30809587 0.80 HPGD (0.52) KDM4EALDH1A1HSD17B10ALOX15MEN1
SCHEMBL30343721 0.79 MAPK1 (0.67) KDM4EALDH1A1HSD17B10ALOX15KMT2A
SCHEMBL19994519 0.79 MAPK1 (0.67) KDM4EALDH1A1HSD17B10ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100273-A TOPOISOMERASE INHIBITOR ANTITUMOR AGENT GLAXO WELLCOME INC. (US) 2000-08-08 US disclosed
US-5559235-A ANTITUMOR GLAXO WELLCOME INC. (US) 1996-09-24 US disclosed
EP-0540099-B1 Water soluble camptothecin derivatives GLAXO WELLCOME INC (US) 1996-04-17 EP disclosed
EP-0673380-A1 WATER SOLUBLE CAMPTOTHECIN DERIVATIVES GLAXO WELLCOME INC. (US) 1995-09-27 EP disclosed
US-5342947-A Treating alkylenedioxy-7-trihaloacetamidomethylenecamptothecin with hydrochloric or sulfuric acid to yield amine salt, treating with alkali metal hydroxide or carbonate to obtain free base GLAXO INC. (US) 1994-08-30 US disclosed
WO-1994011377-A2 WATER SOLUBLE CAMPTOTHECIN DERIVATIVES GLAXO INC. (US) 1994-05-26 WO disclosed
EP-0540099-A1 Water soluble camptothecin derivatives GLAXO WELLCOME INC. (US) 1993-05-05 EP disclosed